PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008 2010 2011 2012 2013 2014 2015
The Partnership for Supply Chain Management Systems (SCMS) was established to strengthen or establish secure, reliable, cost-effective and sustainable supply chains to meet the care and treatment needs of people living with or affected by HIV and AIDS. In collaboration with in-country and international partners, SCMS works to employ innovative solutions to assist programs to enhance their supply chain capacity; ensuring that accurate supply chain information is collected, shared and used; and providing quality, best-value, health care products to those who need them.
In Uganda, SCMS will no longer provide technical support to the MOH and other government agencies for supply chain management system. This support will now be provided by the new SURE (Securing Ugandans' Right to Essential Medicines) project, the activities of which are described in the OHSS section. SCMS will, however, continue to provide ARV procurement services to PEPFAR implementing partners. The number of partners procuring ARVs through SCMS will increase from two to the following seven partners: Inter-Religious Council of Uganda (IRCU), Northern Uganda Malaria AIDS and TB program (NUMAT), Strengthening TB and AIDS Response East (STAR-E) and STAR East Central, and STAR-South West. SCMS will also provide procurement services to the TREAT (JCRC) program during the period Oct 2009 to Sept 2010 to ensure uninterrupted supplies while the program is in a transition period.
The procurement support will be provided by a fulltime national trained by SCMS HQ on procurement policies, procedures and software tools, who will assist programs to forecast and quantify their ARV requirements, updated quarterly, throughout the year. and update their . ceas: The procurement services include
To ensure uninterrupted supply of ARVs to seven partners in the coming year, two fulltime in-country SCMS staff will be managing the procurement process (quantification preparation, submission of orders, shipment tracking, communication with HQ, USAID, partners) and oversee the customs clearance, NDA verfication, and storage and distribution services provided by Joint Medical Stores. Assistance in quantification will also be provided to partners as needed. The SCMS staff will be housed with the new SURE project to reduce administrative costs.
HTXD budget $17,112,375 (unable to paste into planned amount)
SCMS will procure the following list of ARVs for seven USG partners. The JCRC/TREAT program has always procured its own products but in FY 2010, SCMS will do their procurement to ensure no supply disruptions as this program undergoes a transitioning period. JCRC uses the widest range of products of any partner because they have the most mature program and have conducted a number of ART research studies which may have included drugs not in the clinical treatment guidelines.
Abacavir(ABC)( 300mg), Atazanavir (as sulfate) 300mg , Darunavir [Prezista] 300MG/tab, Didanosine (DDI) (200mg), Didanosine EC (DDI) (250mg), Didanosine EC (DDI) (400mg), Efavirenz (EFV) (600mg), Indinavir (IDV) (400mg) (Crixivan), Lamivudine (3TC) (150mg), Lopinavir / Ritonavir (LPV/r) (200/50mg), Nevirapine (NVP) (200mg), Stavudine 30 (d4T30) (30mg), Stavudine 30 / Lamivudine (d4T30/3TC) (30/150mg),
Stavudine 30 / Lamivudine / Nevirapine (d4T30/3TC/NVP) (30/150/200mg), Saquinavir (SQV) (500MG), Ritonavir (RTV) (100MG), Tenofovir (TDF) (300mg), Tenofovir / Emtricitabine (TDF/FTC) (300/200mg), Tenofovir disoproxil fumarate-Lamivudine (300+150mg), Zidovudine (AZT) (300mg), Zidovudine / Lamivudine (AZT/3TC) (300/150mg
Products procured by Clinton Foundation that SCMS will procure when CF ceases their pediatric drug procurement: Abacavir (ABC) (20mg/ml), Abacavir (ABC) (20mg/ml), Didanosine (DDI) (50mg), Didanosine (DDI) (100mg), Efavirenz (EFV)(50mg), Efavirenz (EFV) (200mg), Lamivudine (3TC) Syrup (10mg/ml), Lopinavir / Ritonavir (LPV/r) Oral Solution (80/20 mg/ml), Lopinavir-Ritonavir [Pediatric Aluvia] (100+25MG), Nevirapine (NVP) Syrup (10mg/ml), Stavudine 15 (d4T15) (15mg), Stavudine 20 (d4T20) (20mg), Stavudine (d4T) Syrup (1mg/ml), Stavudine / Lamivudine / Nevirapine (d4T/3TC/NVP) (6/30/50mg)-Triomune Baby, Stavudine / Lamivudine / Nevirapine (d4T/3TC/NVP) (12/60/100mg)-Triomune Junior, Zidovudine (AZT) (100mg), Zidovudine (AZT) Syrup (10mg/ml).
The two partners receiving SCMS procurement services this past year did not experience any stock outs.
